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Abstract
Protein kinase signaling cascades control most aspects of cellular function. The ATP binding domains of signaling protein
kinases are the targets of most available inhibitors. These domains are highly conserved from mammals to flies. Herein we
describe screening of a library of small molecule inhibitors of protein kinases for their ability to increase Drosophila lifespan.
We developed an assay system which allowed screening using the small amounts of materials normally present in
commercial chemical libraries. The studies identified 17 inhibitors, the majority of which targeted tyrosine kinases
associated with the epidermal growth factor receptor (EGFR), platelet-derived growth factor (PDGF)/vascular endothelial
growth factor (VEGF) receptors, G-protein coupled receptor (GPCR), Janus kinase (JAK)/signal transducer and activator of
transcription (STAT), the insulin and insulin-like growth factor (IGFI) receptors. Comparison of the protein kinase signaling
effects of the inhibitors in vitro defined a consensus intracellular signaling profile which included decreased signaling by
p38MAPK (p38), c-Jun N-terminal kinase (JNK) and protein kinase C (PKC). If confirmed, many of these kinases will be novel
additions to the signaling cascades known to regulate metazoan longevity.
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Introduction
Protein kinase signaling cascades control most aspects of cellular
function. As would be expected, many of the known mechanism
for increasing the longevity of metazoans involve conserved
protein kinase signaling cascades (reviewed in [1,2]. In the best
known example, reduction in insulin and/or insulin-like growth
factor I signaling increases the lifespan of C. elegans, Drosophila
melanogaster, and mus musculus (Reviewed in [1,2]). Reduced
signaling through these pathways may account for much of the
life- and health-span effects of caloric restriction [1–3].
Drosophila is an attractive system for the identification and study
of conserved pathways of lifespan regulation. Inhibitors of the
mammalian receptor tyrosine kinases have been found to be
effective against their insect orthologs [4]. Small molecule
inhibitors typically bind the ATP binding pocket of signaling
kinases, inhibiting their activity [5]. For example, the amino acid
sequence of the human and Drosophila EGFR ATP binding fold are
identical, and their surrounding amino acids are also highly
conserved (Figure S1). Because of this similarity, the cancer
therapeutics gefitinib and erlotinib are high affinity inhibitors of
both the Drosophila and human EGFRs [4].
Herein we describe screening of a protein kinase inhibitor
library (Table S1) for the effects of the inhibitors on Drosophila
lifespan. We developed an assay which was able to utilize the small
quantities of drugs typically available in chemical libraries. We
found multiple kinase inhibitors, some targeting novel pathways,
which were capable of extending Drosophila lifespan.
Results and Discussion
Protein kinase inhibitor library screening
Chemical library screening using Drosophila posed a number of
challenges. Chemical libraries are typically composed of small
amounts of drugs. We developed methods for utilizing these small
amounts to conduct lifespan assays with adult Drosophila.T o
increase the efficiency of the screenings, embryo densities [6,7],
culture temperature [8,9], and dietary protein concentrations
[8,10] were adjusted to produce average lifespans of 20 to 30 days
(Figure 1). These lifespans allowed rapid library screening. Our use
of a single bottle throughout the assays might have shortened
lifespans. However, the medium contained inhibitors of fungal and
bacterial growth (propionic acid and Tegosept; Supporting
Information S1) and the food-containing lids were changed
twice-weekly. In no case did we find evidence of fungal or
bacterial growth in the bottles or food. Never-the-less, we cannot
exclude the possibility that the kinase inhibitors extended the
lifespan of the flies by protecting them from the lifespan shortening
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lifespan per se. In future work, it will be important to monitor
effects of the compounds under conditions where control flies
exhibit longer lifespans.
Females have been used for longevity studies because of their
greater response to protein and carbohydrate restriction [8].
However, males were used here to avoid the confounding effects of
egg laying, which affects energy utilization, and therefore
longevity.
The optimum concentration of an inhibitor in lifespan studies is
related to its IC50, as well as its differential stability, uptake,
metabolism, and excretion. Because these effects are difficult to
predict, the inhibitors were tested at two concentrations, differing
by 9-fold, termed low (0.5 mM) and a high (4.5 mM). Of the 80
inhibitors in the library (Table S1), 19 showed a statistically
significant increase in lifespan at one or both of these
concentrations. Of these inhibitors, 17 passed one or more
secondary screenings (Table 1). The secondary screenings also
were used to determine the dose-response of the longevity effects.
For example, 5 mM erbstatin analogue was found to increase
lifespan by approximately 18% at 5 mM (Figure 1A), while 50 mM
staurosporine increased lifespan by about 35% (Figure 1B).
The targets of each of the 17 inhibitors, and their IC50s for these
targets are shown in Table S2. The majority, at least 13 of these
inhibitors, target signaling systems originating with one or more of
the receptor tyrosine kinases (RTK; Tables S2 and S3). These
kinases include the EGF, PDGF/VEGF, insulin/IGFI, JAK and
GPC receptors. Downstream kinases which appear to be
important for the longevity responses include p38, JNK and
PKC (Tables 2 and S3).
Lifespan extension by the inhibitors was not due to
reduced caloric consumption
To investigate whether the effects on lifespan were the result of
induced caloric restriction (CR), we determined the effects of 12 of
the 17 inhibitors on food consumption using two of the best
documented methods, Fecal Plaque Assays (FPAs; [11,12]; Tables 2
and S2) and CAFE assays [13] (Table 2 and Table S5). The results
obtained with the two assays are highly correlated (Pearson’s
coefficient=0.9608; Figure S2). Drug treatment had no detectable
effect on fecal plaque size (Figure S3 and Table S6; Ref. [14]).
Both assays were utilized because the CAFE assay is a more widely
used method of measuring food consumption, but the FPA more
closely measured food intake under the conditions used for our
lifespan studies. We found no effects on food consumption for any
of the inhibitors tested using either assay (Summarized in Table 1;
Tables S4 and S5). Together, these data indicate that the effects of
the inhibitors on Drosophila lifespan do not involve CR.
Effects of the inhibitors on intracellular protein kinase
signaling
The changes in intracellular signaling induced by the inhibitors
were investigated using protein extracts of control and drug
treated S2 cells and Drosophila. Western blots were probed with
antibodies specific for the phosphorylated and non-phosphorylated
forms of the kinases. Changes in phosphorylation state were
regarded as evidence of increased or decreased signaling by that
kinase. Many signaling kinases were readily detected using extracts
of cultured cells (Figures 2, 3, 4, 5). Representative Western blots
are shown in Figures S4, S6, and S7. The position of these kinases
in a consensus signaling network is illustrated in Figure 6. Fewer
kinases could be detected in extracts of adult flies (Figures 7 and 8).
Representative Western blots are shown in Figures S5 and S8. The
phosphorylation states of some signaling kinases from adult flies
were more difficult to detect than those from cultured cells,
perhaps due to lower levels in the flies.
The effects of the inhibitors which extended lifespan on
intracellular kinase signaling are summarized in Table 2. Consid-
ered together, the inhibitors reduced signaling by multiple RTKs,
GPCR, JAK/STATs, and their downstream effectors. This
inhibition produced changes in the activity of downstream kinases
including Mek, p38, JNK, and PKC (Table 2). With few
exceptions, signaling by ERK and AMPK were not strongly
affected. In some cases, both the level of phosphorylation and the
level of the kinase protein was altered by the inhibitors.
Figure 1. Rescreening results of drugs identified in an initial screening the Biomol protein kinase inhibitor library. Panel A shows the
survival results obtained with erbstatin analogue at zero (#), 1.0 mM (n), 5.0 mM (,), and 10 mM (m). The lifespan of the flies was significantly
increased when they were treated with 5 mM (P,0.0001) and 10 mM (P,0.0001), but not when treated with 1 mM (P=0.7328) drug, as judged by
the log rank test. Panel B shows the survival results obtained using staurosporine at zero (#), 10 (%), 30 (n), and 50 mM( .). The lifespan of the flies
was significantly increased when they were treated with 10 (P=0.0038), 30 (P,0.0001), or 50 mM( P ,0.0001) drug, as judged by the log rank test.
doi:10.1371/journal.pone.0029782.g001
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A novel result was that multiple inhibitors of EGFR tyrosine
kinase activity extended Drosophila lifespan. As discussed above, the
inhibitor binding sites of the human and Drosophila RTKs are
structurally and functionally highly conserved, since most such
inhibitors target the ATP binding fold (Figure S1; Refs. [4,5]). We
found that the EGFR inhibitors Tyrphostin AG1478 (AG1478),
Erbstatin analogue, and Tyrphostin 1 produced similar, but not
identical, effects in Drosophila S2 cells (Figures 2 and 3;
Summarized in Table 2). All three drugs produced relatively
modest effects on Mek1/2 and ERK1/2 signaling, which were
either reduced or unchanged (Figures 2 and 3). These modest
effects may have been due to the dosing regimen used. The highly
selective Mek1/2 inhibitor PD-98059 significantly reduced Mek1/
2 activity, and slightly, but not significantly, reduce the activity of
its downstream target ERK1/2 (Figures 2 and 6; Data
summarized in Table 2). Unexpectedly, inhibition of the PDGF
receptor/VEGF receptor (PDGFR/VEGFR) homologue by
tyrphostin 9 strongly activated Mek and ERK1/2 signaling,
without changing their protein levels (Figure 3). These results
suggest that PDGFR/VEGFR signaling represses EGFR activity
in Drosophila cells in culture. However, in vivo tyrphostin 9 slightly
reduced ERK1/2 signaling (Figure 8). These contrasting effects in
cultured cells and flies are likely related to the differential uptake,
metabolism or excretion of the drugs.
JNK
The high affinity EGFR inhibitors AG1478 and Erbstatin
analogue elevated JNK signaling in cells, without altering JNK
protein levels (Figures 2 and 3). AG1478 also increased JNK
signaling in flies (Figures 7A–C; Summarized in Table 2).
Moderate JNK activation increases longevity and stress tolerance
in Drosophila, C. elegans and mice ([15–18]; Reviewed in [19]).
Thus, increased JNK activity may be the source of the lifespan
effects of these inhibitors. In Drosophila, JNK activation reduces
insulin (LnR in Drosophila) signaling by antagonizing IRS/Chico
activation, leading to increased DAF-16/FOXO activity and
increased lifespan [19]. As discussed in the paragraph above, the
contrasting effects of SP600125 in flies and cells are likely related
to its differential uptake, metabolism or excretion.
PDGFR/VEGFR
Two PDGFR/VEGFR inhibitors, Tyrphostin AG1295 and
Tyrphostin 9, extended Drosophila lifespan (Table 1). The
PDGFR/VEGFR homologue in Drosophila, Pvr, signals through
the canonical Ras/ERK pathway (Table S3). As discussed above,
active Pvr appears to repress signaling through the Drosophila
EGFR homologue (Torpedo/DER) in cell culture, since Tyrphos-
tin 9 strongly upregulated both Mek and ERK signaling in cells
(Figure 3). PDGFR inhibition by tyrphostin 9 also reduced
signaling by p38, JNK, and PKC in S2 cells, but strongly induced
AMPK signaling in flies (Figures 3, 6A and 7E). Increased AMPK
signaling is closely associated with increased longevity in a number
of metazoan systems [2]. Reduced p38 activity is not normally
associated with increased longevity. However, in the studies
reported here, lifespan extension is often accompanied by reduced
p38 signaling (summarized in Table 2). For the reasons discussed
in the JNK section above, reduced JNK activity is unlikely to
contribute to the longevity effects of Tyrphostin 9. Thus, increased
AMPK and p38 activity appear to be the likely reason for the
positive effects of Pvr inhibition on lifespan.
Table 1. Results obtained with the inhibitors which passed the initial screening.
Biomol ID# Compound name Rescreening results
a Optimum concentration Food consumption
b
B1 PD-98059 27% (2) 300–1000 mMN C
B3 SB203580 30.3% (3) 300 mMN C
B6 Staurosporine 34.8% (3) 30–50 mMN C
C4 Tyrphostin 1 19.0% (2) 100–300 mMN C
C6 Tyrphostin AG1478 19.5% (2) 100 mMN C
C7 Tyrphostin AG1295 22.5% (2) 300–500 mM
C8 Tyrphostin 9 17.3% (3) 300–500 mMN C
D1 AG-490 17.5% (2) 300 mM
E1 HA-1004 18% (2) 1–10 mMN C
E2 HA-1077 14.5% (2) 10 mMN C
E5 KN-93 20% (3) 10–100 mM
F4 PP2 AG1879 22.8% (1) 300 mM
G1 Erbstatin analog 18% (1) 5 mM NC
G2 Quercetin dihydrate 23% (3) 1 mM NC
G8 SP600125 23.5% (2) 10 mM NC
G9 Indirubin 8.2% (3) 3 mM
H8
c Everolimus 16.6% (3) 3 mM NC
aPercentages indicate the average percent increase in mean lifespan obtained in the number of independent trials indicated in parentheses. Because maximum lifespan
(lifespan of the longest lived 10%) was variable due to the presence of occasional long-lived outliers, this metric was not used.
bNC indicates that the effects of the drugs on food consumption were not statistically different than control in FPAs and/or CAFE assays (see Materials and Methods for
the details of the assays and statistical tests used). These FPAs used 6 control and 6 treated 8 ounce fly bottles containing 30 to 50 flies each. The absence of a notation
indicates that the test was not performed for that drug. Where a range of optimum concentrations of the drug is given, the assay was performed at the highest
concentration in the range.
cH8 was rapamycin (sirolimus) in the Biomol library. Because of its poor bioavailability, we tested everolimus, its more bioavailable derivative.
doi:10.1371/journal.pone.0029782.t001
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p38 activity was downregulated in S2 cells by 7 of the 11
inhibitors which lengthened lifespan (Figures 2 and 3). SB203580 is
a highly specific inhibitor of p38 (Table S2), and it both reduced the
activity of its target and increased lifespan (Figure 2; Table 1). The
p38 pathway has an evolutionarily conserved role in inflammatory
signaling and the innate immune response in Drosophila [20]. Pro-
inflammatory signaling mediated by p38 during aging has been
associated with age-related pathology and attenuated lifespan [21].
In accord with these effects, 7 of the 11 inhibitors which extended
lifespan reduced p38 signaling (Table 2). Thus, reduced p38
signaling is associated with increased longevity in our study.
PKC
In general, inhibitors that increased lifespan decreased the level of
PKC activity in S2 cells and intact flies (Figures 6 and7F; Table 2). The
decreased PKC signaling induced by AG1478, an EGFR inhibitor, in
cells and flies (Fig.5A and 6) is consistent with the reported activation of
PKC by EGFR in mammalian cells, which suggests evolutionary
conservation of this pathway between flies and mammals [22].
AMPK
Two lifespan-lengthening inhibitors reduced AMPK activity in
vivo, staurosporine and AG1478 (Figure 7D), and staurosporine
also reduced AMPK levels in Drosophila cells in vitro (Figure 5). In
contrast, two other inhibitors, tyrphostin 1 and tyrphostin 9,
increased AMPK activity in vivo (Figure 7E). Increased, rather than
reduced, AMPK signaling is normally associated with extended
lifespan [23]. Enhanced AMPK signaling can extend the lifespan
of both Drosophila and C. elegans [24,25], while reduction of AMPK
signaling can shorten Drosophila lifespan [26,27]. Together, these
results suggest that increased AMPK signaling contributes to the
longevity effects of tyrphostin 1 and tyrphostin 9, but not to the
effects of staurosporine and AG1478.
Genetic reduction of AMPK signaling was reported to induce
hyperphagia in Drosophila, as determined using CAFE assays [26].
In contrast, we found no effects of staurosporine or AG1478 on
food consumption (Tables 1 and S4). The reasons for these
differences are not clear. It is possible that the kinase inhibitors did
not reduce AMPK levels in the hypothalamic compartment which
regulates feeding behavior.
Staurosporine, HA-1004 and HA-1077
Staurosporine, a high affinity inhibitor of PKC (Table S2),
inhibited signaling by PKC and AMPK in vivo, and signaling by all
the other protein kinases tested in vitro, including JNK (Figures 2, 4,
5 and 7; Table 2). HA-1004 and HA-1077, which share many
targets with staurosporine, also reduced signaling by JNK (Figures 2
and 4; Table 2). Reduced JNK signaling may be the mechanism for
the lifespan extension by these inhibitors (as discussed above).
However, it is important to note that staurosporine significantly
increased JNK activity in vivo (Figure 7A–C). Thus, it is clear that
other protein kinase targets must also be important for increased
lifespan. For example, erbstatin analogue, indirubin, and tryphostin
1 did not decrease the JNK activity, but did increase lifespan. These
drugs inhibited p38 activity, and this inhibition may explain their
lifespan effects (as discussed above).
Consensus response to the inhibitors
The consensus in vitro effects of the inhibitors on intracellular
signaling are shown near the bottom of Table 2. No inhibitor
which extended lifespan differed in more than two ways from this
consensus response. The most highly conserved aspects of the
consensus response are decreased PKC signaling, followed by
decreased p38 and Mek signaling. These results suggest that these
responses are key to increased Drosophila lifespan using the methods
employed for these studies.
Reasons for the differential effects of some kinase
inhibitors in flies versus cell culture
Some inhibitors had different effects on protein kinase activity in
cells and flies (Table 2). As discussed here, these differences most
probably arise from differences in the uptake, bioavailability,
stability, metabolism, or excretion in vivo versus in cell culture. Off
target effects are also possible, but are less likely because of the
high structural and functional conservation of the regions of the
protein kinases targeted, as discussed.
Effects of the kinase inhibitors in intact flies
Five of 6 of the inhibitors tested increased the relative
concentration of ERK1/2 in intact Drosophila, although only one
of these, the EGFR inhibitor AG1478, actually increased signaling
by this protein (Figure 8). In one example of this effect,
staurosporine doubled the amount of ERK1/2 protein present
Table 2. Summary of protein kinase activity studies.
Drug Target(s) Mek ERK p38 JNK PKC AMPK
AG-490 (D1) JAK2 (NC)
a(Q)N C N C
Erbstatin Analogue
(G1)
EGFR NC NC Qq q Q NC
HA-1004 (E1) PKG Q NC qQ Q NC
PKA
CaMKII
PKC
HA-1077 (E2) ROCKI/II Q NC NC QQ NC NC
PRK2
MSK1
Indirubin (G9) GSK3b sq NC Q NC Q NC
PD98059 (B1) Mek Q NC NC Q NC NC
SB203508 (B3) p38 QQ Q sQ NC QQ
SP600125 (G8) JNK q NC Qq q Q NC
(Q)( Q)( Q)
Staurosporine (B6) PKC QQ Q sQ Q QQ QQ
(q) (NC) (q)( Q)( Q)
Tyrphostin EGFR Q NC qq Q NC
AG1478 (C6) (q)( q)( qq)( Q)( QQ)
Tyrphostin 9 (C8) PDGFR qq q Q Q QQ Q NC
(Q)( Q) (NC) (qq)
Tyrphostin 1 (C4) EGFR Q NC Q NC Q NC
(Q)( Q) (NC) (q)
Consensus response in
cells:
Q NC QQ Q NC
Down 7 2 7 5 10 2
U p 312 300
N C 182 331 0
aDown or up arrows indicate a decrease or increase in signal relative to control,
respectively (Figure 2). NC indicates no change. A ‘‘s’’ adjacent to an arrow
indicates that the change was small in magnitude. Arrows in parenthesis
indicate changes found in Western blots of protein extracts from drug treated
Drosophila (Figures 3 and 8).
doi:10.1371/journal.pone.0029782.t002
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inhibitors actually increased total ERK1/2 but reduced the
amount of active ERK1/2. Together, these results clearly illustrate
that signaling activity can be regulated independently of the total
amount of kinase protein present.
Conclusions
Inhibition of EGFR, PDGF/VEGF receptor, GPCR, and JAK/
STAT signaling can extend the lifespan of Drosophila. Comparison
of the protein kinase signaling effects of the inhibitors in vitro
defined a consensus intracellular signaling profile which included
decreased signaling by p38, JNK and PKC. Many of these results
are novel, and if confirmed, they will expand the number of
signaling cascades known to regulate metazoan lifespan.
Materials and Methods
Protein kinase inhibitor library
A chemical library of 80 kinase inhibitors was purchased from
Biomol International (now Enzo Life Sciences International, Inc.,
Figure 2. Effects of the protein kinase inhibitors on intracellular signaling in Drosophila S2 cells treated for 48 hours with the
protein kinase inhibitors indicated at the bottom of the panels. Panel A shows data obtained using antibodies to phospho-Erk1/2 (white
bars), and total Erk1/2 (black bars). Panel B shows data obtained using antibodies to phospho-Mek1/2 (white bars), and total Mek1/2 (black bars).
Panel C shows data obtained using antibodies to phospho-p38 MAPK (white bars), and total p38 MAPK (black bars). Panel D shows data obtained
using antibodies to phospho-JNK (white bars), and total JNK (black bars). The height of each bar represents the the signal normalized to the total
amount of protein in each sample as judged by comparison to several apparently invariant protein bands observed on the blot by Ponceau S staining
(representative staining is shown in Figure S4A). One asterisk indicates the changes were significant (P#0.05); two asterisks indicates the results were
highly significant (P#0.01), and three indicates it is very highly significant (P#0.001). See Figure S4A for representative Western blots and protein
bands visualized using Ponceau S staining of membranes.
doi:10.1371/journal.pone.0029782.g002
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10 mM solution in DMSO. This library was stored at 220uC until
used. Wild-type Oregon-R-C Drosophila were obtained from the
Bloomington Drosophila Stock Center (Department of Biology,
Indiana University, Bloomington, IN, (http://flystocks.bio.indiana.
edu/). All the protein kinases inhibitors used in the second round of
testing (AG-490, erbstatin analog, HA-1004, HA-1077, hypericin,
indirubin, KN-93, PD-98059, PP2 AG1879, SB203580, SP600125,
staurosporine, tyrphostin 1, tyrphostin 9, tyrphostin AG1478) were
from Enzo Life Sciences, except for tyrphostin AG1295, which was
from Santa Cruz Biotech.
Protein kinase inhibitor library screening for effects on
Drosophila lifespan
In initial screening studies, 10 and 90 ml of each of the 10 mM
protein kinase inhibitor stock solution obtained from Biomol was
diluted to a final volume of 200 ml with DMSO, to make working
solutions of 0.5 mM (low) and 4.5 mM (high). In initial studies,
10 ml aliquots of each solution were added to 0.5 ml of SY paste
[28], mixed well with a spatula, and 0.25 or 0.125 ml of the
mixture spread evenly onto the surface of 35610 mm Petri dish
lids (Falcon) containing a 5.5 ml plug of 10 g/L agar and 10 mM
Tegosept. Controls utilized 10 ml of DMSO mixed and spread as
described above. The filled Petri dish lids were used as bottle
closures by placing them over the opening of 8 ounce, plastic fly
bottles (Genesee Scientific), and securing them with tape. For the
reasons enumerated in Results and Discussion, later screening studies
were performed using Petri-dish bottle closures prepared by
carefully applying 10 ml of DMSO (control), the low or the high
concentration protein kinase inhibitor working solutions directly to
the surface of the SCM-agar (see Supporting Information S1)
containing Petri-dish bottle closures, and spreading the solutions
Figure 3. Effects of the protein kinase inhibitors on intracellular signaling in Drosophila S2 cells treated for 48 hours with the
protein kinase inhibitors indicated at the bottom of the panels. The antibodies used to obtain data for each panel and the color coding of
the data bars are as described for Figure 2. Data normalization was performed as described in Figure 2. The symbols indicating statistical significance
are as in Figure 2. See Figure S4B and C for representative Western blots and Ponceau S stained protein.
doi:10.1371/journal.pone.0029782.g003
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the micropipette tip. In a later variation, the drug aliquots were
mixed with 0.5 ml of SCM before they were layered onto the
SCM agar-containing bottle closures. The SCM-agar closures
were prepared beforehand, and stored at 4uC for up to several
weeks before being warmed to room temperature for use. Thirty to
50 flies in each of 4 to 8 bottles (200 to 240 flies total) were used for
each control or treatment group. The bottles were closed with
Petri dish lids secured with tape. The walls of the fly bottles were
pierced with small air holes, and the bottles incubated at 60%
humidity, on a 12:12 hour light:dark cycle, with the lid closures on
top to minimize evaporative drying. As discussed in Results and
Discussion, a few initial longevity studies were conducted at 29uC.
The temperature was reduced to 25uC, and this was used for most
of the studies. The Petri-dish bottle closures were replaced twice
weekly. The number of flies living at each time point was
determined by visual inspection. CO2 anesthesia was not used
after the initial sorting of the males. Studies using dyes in the 10 ml
DMSO overlays indicate that the drug diffuses approximately 1–
2 mm into the SCM-agar in 72 hours at 25uC. See Supporting
Information S1 for more detail. Lifespan differences between
vehicle and drug treated groups were determined using survival
analysis followed by the Logrank test (SAS).
Quantification of fly food intake
Food intake was quantified in two ways. Capillary feeder
(CAFE) assays [13] were modified for 30 flies in eight ounce plastic
fly bottles with four, 100 ml graduated glass microcapillary pipettes
containing 5% sucrose, 5% autolyzed yeast extract (Fisher), and
0.01% (v/v) DMSO either alone (control) or containing the
Figure 4. PKC activity determined using antibodies to phosphorylated substrates of PKC in extracts of S2 cells treated for 48 hours
with the indicated protein kinase inhibitors. Panels A and B show results for different subsets of the inhibitors. The labeling and symbols are as
described in the legend to Figure 2. See Figure S6 for representative Western blots.
doi:10.1371/journal.pone.0029782.g004
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Western blots prepared using protein extracts of S2 cells treated for 48 hours with the protein kinase inhibitors. Panels A and B show
the data from one of two Western blots using control cells or cells treated with the indicated inhibitors. The labeling and symbols are as described in
the legend to Figure 2. See Figure S7 for representative Western blots.
doi:10.1371/journal.pone.0029782.g005
Figure 6. An abridged, consensus, protein-kinase signaling network assembled by examination of the Drosophila and mammalian
literature. It is presented to elucidate some of the possible interconnections and ‘‘cross-talk’’ between these signaling systems. The proteins boxed
in dashed lines indicate signaling kinases for which we identified inhibitors which extended lifespan.
doi:10.1371/journal.pone.0029782.g006
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food coloring was added to facilitate measurements. The cotton
Flug bottle closures were saturated with 25 ml of reverse osmosis
purified water to maintain humidity during the 24 hour
incubation at 25uC.
FPAs were performed essentially as described [12], with minor
modifications. Briefly, standard SCM-agar Petri dish lids were
prepared. One-half ml of SCM without agar was mixed with 10 ml
of DMSO without (control) or with 10 ml of the indicated
concentration of drug and one drop of red food coloring, and
evenly spread over the surface of an SCM-agar lid. The lids were
used to feed bottles of 50 flies for 24 hours. After removal of the
lids and the flies, 5, 464 cm squares were randomly marked on the
sides of each bottle near the midline, and the numbers of red
plaques counted. Fly bottles from FPAs were positioned under a
Celestron Handheld Digital Microscope, Model #44302-A, and
their diameter determined using the software provided (n=40 for
each condition). The mean number of plaques per square
centimeter and plaque diameter was compared by t-test or one
way ANOVA using GraphPad Prism.
Figure 7. Effects of the indicated protein kinase inhibitors on site-specific phosphorylation determined using Western blots
prepared using whole body protein extracts of Drosophila treated with various protein kinase inhibitors. Shown in panels A, B and C
are the results obtained with antibodies specific to phosphorylated and total JNK; in panel D and E, the results obtained with antibodies to
phosphorylated and total AMPK; and in panel F the results from antibodies to phosphorylated substrates of PKC. The inhibitors used in each study are
indicated at the bottom of the panels. The symbols are as described in the legend to Figure 2. See Figure S5 for representative Western blots. In panel
E, the control phosphorylated-AMPKa expression levels are derived from the averages of only 2 independent replicates, due to sample loss. All other
data are derived from 3 independent replicates. See Figure S5 for representative Western blots.
doi:10.1371/journal.pone.0029782.g007
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Drosophila S2 cells (a gift from DRSC at Harvard Medical
school) were grown at 28uCi n1 6Schneider’s Drosophila medium
(Gibco) supplemented with 10% FBS. Aliquots of 2610
6 cells were
seeded in 75 cm
2 plastic tissue culture bottles and grown for 1 day
before the kinase inhibitors, dissolved in DMSO, were added. A
second inhibitor dose was added on the third day. DMSO treated
cells were used as control. Cells were collected on the fourth day,
snap frozen in liquid nitrogen, and stored at 280uC. The final
dose of each inhibitor was: Tyrphostin AG1478, 40 mM;
tyrphostin 1, 20 mM; tyrphostin 9, 20 mM; PD-98059, 40 mM;
staurosporine, 0.04 mM; SB- 203580, 4 mM; HA-1004, 80 mM;
HA-1077, 20 mM; erbstatin analog, 20 mM; SP600125, 20 mM;
Indirubin, 20 mM.
Western blotting of proteins isolated from Drosophila
Controls or Drosophila treated with protein kinase inhibitors at
their optimum dosage for lifespan extension were snap frozen, and
stored at 280uC. Four bottles per treatment group, with 50 male
flies per bottle, were powdered under liquid nitrogen with a
mortar and pestle. Soluble and membrane bound proteins were
fractionated using a ProteoJET Membrane Protein Extraction Kit
(www.fermentas.com) as described by the supplier, except that the
Cell Permeabilization and Membrane Protein Extraction Buffers
contained protease inhibitor cocktail (10 ml per ml; Sigma
#P8340). After extraction, the total soluble and membrane bound
fractions were combined and used for Western blot analysis.
Separate extraction of soluble and membrane bound fractions
gave a higher protein yield and intact proteins relative to any total
protein extraction method used. Proteins (100 mg per lane) were
separated by SDS-PAGE, transferred to a PVDF membrane, and
images developed by ECL chemiluminescence according to
standard procedures. The membranes were probed using
antibodies directed against phospho-p38 MAPK (Thr180/
Tyr182) (Cell Signaling, #9216), p38 (Santa Cruz Biotechnology,
#sc-15714), phospho-p44/42 MAPK (ERK1/2; Thr202/Tyr204)
(Cell Signaling, #9101), p44/42 MAPK (Erk1/2) (Cell Signaling,
#4348), phospho-Mek1/2 (Ser 218/Ser222) (Santa Cruz Biotech-
nology, #sc-7995), MEK1/2 (Cell Signaling, #9122), phospho-
SAPK/JNK(Thr183/Tyr185) (CellSignaling,#4668),JNK(Santa
Cruz Biotechnology, #sc-571), phospho-AMPKa (Thr172) (Cell
Signaling, #4188), AMPKa1+AMPKa2 (Abcam, #ab80039),
phospho-(Ser) PKC Substrate (Cell Signaling, #2261), calnexin
(Abcam, #ab75801), and b-actin (Abcam, #ab20272). Secondary
antibodies conjugated to horseradish peroxidase, were either goat
anti-rabbit IgG (Abcam, ab6721# ), rabbit anti-mouse IgG
(Abcam, ab6728#), or donkey anti-goat IgG (Santa Cruz
Biotechnology, sc-2020#). Protein loading was determined using
Ponceau S staining of PVDF membranes and unregulated protein
bands were identified by visual inspection of the stained
membranes. Ponceau S staining was utilized rather than antibody
probing for a single ‘‘control protein’’ because such probing would
limit our observations to this single control. Differential regulation
of the control byone ofthemany treatments could be mistaken for a
variations in loading. In contrast, observation of a large number of
proteins on the stained membrane reduces the likelihood of this
possible artifact. Band intensity was quantified with NIH ImageJ or
Kodak Molecular Imaging Software, Standard Edition (Carestream
Health, Inc.). Phosphorylation levels were normalized for protein
loading and the data plotted using GraphPad Prism (version 5.01,
www.graphpad.com). Statistical significance between DMSO
treated and kinase inhibitor treated samples was determined with
a two-sample t-test, assuming equal variances. In multiple studies
using a variety of protein isolation techniques, only the signals for
the antibodies utilized in Figures 7 and 8 (phospho-(Ser) PKC
substrate, phospho-JNK, phospho-ERK1/2, and b-actin) repro-
ducibly produced signals above background using proteins isolated
from intact flies.
Figure 8. The effects of protein kinase inhibitors on the activation of ERK1/2 signaling in intact Drosophila. ERK1/2 activation in
Drosophila fed the inhibitors in their food were determined using Western blots probed with a phosphorylation site- or total protein-specific
antibody. The labeling and symbols are as described in the legend to Figure 2. Panels A through C represent data from 3 different Western blots. See
Figure S8 for representative Western blots.
doi:10.1371/journal.pone.0029782.g008
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cells
Protein extracts were prepared by sonication of cell pellets in
350 mlofSDSbuffer(50 mMTris-HCl,pH 6.8,2%SDS,and10%
glycerol) containing 5 ml/ml protease inhibitor cocktail (Sigma
#P8340) and 5 mL/ml phosphatase inhibitor cocktails 2 and 3
(Sigma #P5726 and P0044) for 20 sec at a setting of 7 (Sonifier
Analog Cell Disruptor, Model S-450A), and centrifugation at
16,0006 g for 20 min. Supernatants were collected and protein
concentrations determined using a Pierce BCA Protein Assay Kit
(Thermo Scientific) as described by the manufacturer. Proteins
(100 mg per lane) were separated by SDS-PAGE, transferred to a
PVDF membrane, membranes probed and the data processed as
described above for proteins isolated from Drosophila.
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Figure S6 Representative PKC-substrate serine phosphorylation
measured using an antibody specific for phospho-(Ser)PKC substrates.
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